Publications

Long COVID: major findings, mechanisms and recommendations

Review Article | Nature Reviews Microbiology | January 2023

Long COVID: major findings, mechanisms and recommendations

Additional publications with external organizations

  1. Episodic disability framework in the context of Long COVID: Findings from a community-engaged international qualitative study February 27, 2025.
  2. Effect of nirmatrelvir/ritonavir (Paxlovid) on hospitalization among adults with COVID-19: An electronic health record-based target trial emulation from N3C January 17, 2025.
  3. Impact of extended-course oral nirmatrelvir/ritonavir in established Long COVID: a case series January 6, 2025.
  4. A cycle of invisibilisation: a qualitative study of Brazilian health system factors shaping access to long COVID care December 21, 2024.
  5. Protocol for an ambidirectional cohort study on long COVID and the healthcare needs, use and barriers to access health services in a large city in Southeast Brazil November 7, 2024.
  6. Finding Long-COVID: temporal topic modeling of electronic health records from the N3C and RECOVER programs October 21, 2024.
  7. Multi-method phenotyping of Long COVID patients using high-dimensional symptom data October 2, 2024.
  8. Long COVID and associated outcomes following COVID-19 reinfections: Insights from an International Patient-Led Survey September 24, 2024.
  9. Long COVID Among People With Preexisting Disabilities August 29, 2024.
  10. Characterizing Long COVID in Children and Adolescents August 21, 2024.
  11. Designing and optimizing clinical trials for long COVID August 13, 2024.
  12. Long COVID science, research and policy August 9, 2024.
  13. Using real-world data to accelerate the search for long COVID therapies August 5, 2024.
  14. Insights from an N3C RECOVER EHR-based cohort study characterizing SARS-CoV-2 reinfections and Long COVID July 11, 2024.
  15. Promoting Equity, Diversity, and Inclusion in Surveys: Insights from a Patient-engaged Study to Assess Long COVID Healthcare Needs in Brazil June 14, 2024.
  16. Hearing on Addressing Long COVID: Advancing Research and Improving Patient Care January 19, 2024
  17. Impact of COVID-19 vaccination on symptoms and immune phenotypes in vaccine-naÏve individuals with Long COVID January 12, 2024.
  18. Return-to-work with long COVID: An Episodic Disability and Total Worker Health® analysis October 20, 2023.
  19. Long COVID research risks losing momentum – we need a moonshot October 18, 2023.
  20. Employment and Material Hardship among Adults with Long COVID in December 2022 July 20, 2023.
  21. Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection May 25, 2023.
  22. Long COVID risk and pre-COVID vaccination in an EHR-based cohort study from the RECOVER program May 22, 2023.
  23. Effect of Nirmatrelvir/Ritonavir (Paxlovid) on Hospitalization among Adults with COVID-19: an EHR-based Target Trial Emulation from N3C, May 4, 2023.
  24. Conceptualising the episodic nature of disability among adults living with Long COVID: a qualitative study March 1, 2023.
  25. Coding long COVID: characterizing a new disease through an ICD-10 lens February 16, 2023.
  26. SARS-CoV-2 Reinfection is Preceded by Unique Biomarkers and Related to Initial Infection Timing and Severity: an N3C RECOVER EHR-Based Cohort Study. January 5, 2023.
  27. Generalisable long COVID subtypes: findings from the NIH N3C and RECOVER programmes December 21, 2022.
  28. A new clinical challenge: supporting patients coping with the long-term effects of COVID-19. October 10, 2022.
  29. Serology Test Results and Other Important Characteristics of Patients With Persistent COVID-19 Symptoms. March 21, 2022.
  30. Long COVID and episodic disability: advancing the conceptualisation, measurement and knowledge of episodic disability among people living with Long COVID–protocol for a mixed-methods study. March 7, 2022.
  31. Studying the post-COVID-19 condition: research challenges, strategies, and importance of Core Outcome Set development. February 4, 2022.
  32. Core Outcome Set for Research and Clinical Practice in Post COVID-19 Condition (Long COVID): An International Delphi Consensus Study ‘PC-COS’. January 31, 2022.
  33. Long COVID in children. January 1, 2022.
  34. Characterizing Long COVID: Deep Phenotype of a Complex Condition. November 25, 2021.
  35. Towards a universal understanding of post COVID-19 condition. October 5, 2021.
  36. Change in Symptoms and Immune Response in People with Post-Acute Sequelae of SARS-Cov-2 Infection (PASC) After SARS-Cov-2 Vaccination. July 28, 2021.
  37. Expanding our understanding of Post Covid-19 Condition, World Health Organization. April 24, 2021.
  38. Challenges in defining Long COVID: Striking differences across literature, Electronic Health Records, and patient-reported information. March 26, 2021.
  39. A Cytokine-based model for the pathophysiology of Long COVID symptoms. November 12, 2020.